Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine

NCT01037855 · clinicaltrials.gov ↗

COMPLETED

Status

4028

Enrollment

INDUSTRY

Sponsor class

Conditions

Novel Influenza A (H1N1)
A New Flu Virus of Swine Origin

Interventions

OTHER: Non-intervention observational study

Sponsor

Novartis Vaccines